Google's AI genome system evaluates every possible one-base change
Google's AlphaGenome AI system predicts functional effects of non-coding DNA variants in humans and mice.
Google's AlphaGenome AI system evaluates genomic sequences to predict gene expression, transcription factor binding, chromatin accessibility, splice site usage, and related genomic features. The system is currently limited to human and mouse sequences and a limited set of well-studied cell types, but its predictions generally match or exceed specialized software tools. Researchers can use it to assess whether non-coding variants are likely significant and generate hypotheses about their function.
- AlphaGenome predicts functional impact of single-base genomic changes
- Limited to human and mouse sequences and studied cell types
- Performance generally matches or exceeds specialized bioinformatics tools
- Vendors
- Products
- AlphaGenome
- AI models
- AlphaGenome
From the original article
1 min read at arstechnica.com
Most one-base changes to the human genome do nothing, but a few are significant.
By John Timmer · arstechnica.com
A short excerpt; the article and its images belong to the publisher. Summary, key facts and assessment above are AI-written from the article and can be wrong.